Early in vitro ADME

Time is of the essence when progressing hits to leads and on to preclinical candidates of drug discovery & development. Swift access to ADME-Tox / in vivo PK data is indispensable for expediting the design-make-test cycle.

We support also projects in need of time-critical early ADME characterization. Our expertise lies in swiftly providing essential information tailored to your project’s needs, with the right assays conducted at the right time. Whether as part of an integrated drug discovery program with Symeres or as a standalone service within the Admescope platform, we’re dedicated to bringing efficiencies to your drug discovery journey. 

As a standalone early in vitro ADME screening, we have automatized assays ensuring obtaining fast and accurate data for solubility, logD, metabolic stability, PPB and CYP inhibition. For frequently occurring screenings, the data is available within a week!